Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres

被引:21
|
作者
Marin, B. [1 ,2 ,3 ]
Beghi, E. [4 ]
Vial, C. [5 ]
Bernard, E. [5 ]
Lautrette, G. [6 ]
Clavelou, P. [7 ]
Guy, N. [7 ]
Lemasson, G. [8 ]
Debruxelles, S. [8 ]
Cintas, P. [9 ]
Antoine, J. C. [10 ]
Camdessanche, J. P. [10 ]
Logroscino, G. [11 ,12 ]
Preux, P. M. [1 ,2 ,3 ]
Couratier, P. [1 ,2 ,6 ]
机构
[1] INSERM, U1094, Trop Neuroepidemiol, Limoges, France
[2] Univ Limoges, UMR S 1094, Inst Neuroepidemiol & Trop Neurol, Trop Neuroepidemiol,CNRS FR GEIST 3503, F-87000 Limoges, France
[3] CHU Limoges, Ctr Epidemiol Biostat & Methodol Rech, Limoges, France
[4] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Neurosci, Lab Malattie Neurol, Milan, Italy
[5] CHU Lyon, Hop Neurol P Wertheimer, Electromyog & Pathol Neuromuscularies, Lyon, France
[6] CHU Limoges, Serv Neurol, Ctr Expert SLA, Limoges, France
[7] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Neurol, Ctr Expert SLA, Clermont Ferrand, France
[8] CHU Pellegrin, Serv Neurol, Ctr Expert SLA, Bordeaux, France
[9] CHU Toulouse Purpan, Ctr Expert SLA, Unite Neurophysiol Clin, Toulouse, France
[10] CHU St Etienne, Hop Nord, Serv Neurol, Ctr Expert SLA, St Etienne, France
[11] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
[12] Univ Bari Aldo Moro, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Pia Fdn Cardinale G Panico, Lecce, Italy
关键词
access and evaluation; amyotrophic lateral sclerosis; clinical audit; healthcare quality; practice guideline; QUALITY STANDARDS SUBCOMMITTEE; PRACTICE PARAMETER UPDATE; AMERICAN ACADEMY; PALLIATIVE CARE; MANAGEMENT; LESSONS; TIME;
D O I
10.1111/ene.12941
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeOur objective was to evaluate the extent to which the 2005 recommendations of the European Federation of Neurological Sciences (EFNS) on the multidisciplinary management of amyotrophic lateral sclerosis (ALS) are followed in clinical practice. MethodsThis was a multicentre observational study involving six French ALS referral centres receiving prevalent and incident cases. Recommendations were translated into ad hoc questions referring to key aspects of management, and their application was evaluated by a clinical research assistant who independently examined the medical charts (MCs). When necessary, an independent board-certified neurologist answered the questions based on examination of the MC and interview of the caring neurologist. Questions regarding diagnosis and communication were put to patients in a self-administered questionnaire. ResultsIn all, 376 patients [176 incident, 200 prevalent cases; median age at diagnosis 62.8 years (interquartile range 55.7-72.3); sex ratio 1.37; 27.3% bulbar onset] were included. All the topics covered in the recommendations were evaluated: diagnostic delay (e.g. mean 13.6 months, associated with age and onset); breaking the news (e.g. criteria for communication quality were satisfactory in more than 90%); multidisciplinary and sustained support (e.g. clinic visits were scheduled every 2-3 months in 90%). Also considered were whether riluzole had been offered, symptom management, genetic testing, ventilation, communication defects, enteral nutrition, palliative and end-of-life care. Characteristics associated with poor compliance with some guidelines (schedule of visits, delayed riluzole initiation) were also identified. ConclusionThis is the first evaluation of the application of the EFNS recommendations for the management of ALS in a nationwide sample. The results allow us to highlight areas for improvement.
引用
收藏
页码:787 / 795
页数:9
相关论文
共 50 条
  • [41] Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria
    Jose Lopez-Gomez, Juan
    Ballesteros-Pomar, Maria D.
    Torres-Torres, Beatriz
    Pintor De la Maza, Begona
    Angeles Penacho-Lazaro, M.
    Palacio-Mures, Jose M.
    Abreu-Padin, Cristina
    Lopez-Guzman, Antonio
    De Luis-Roman, Daniel A.
    CLINICAL NUTRITION, 2021, 40 (01) : 237 - 244
  • [42] Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients
    Salas, Teresa
    Mora, Jesus
    Esteban, Jesus
    Rodriguez, Francisco
    Diaz-Lobato, Salvador
    Fajardo, Maria
    AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (03): : 168 - 172
  • [43] Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients
    Genton, L.
    Viatte, V.
    Janssens, J. -P.
    Heritier, A. -C.
    Pichard, C.
    CLINICAL NUTRITION, 2011, 30 (05) : 553 - 559
  • [44] Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
    Albanese, Alberto
    Ludolph, Albert Christian
    McDermott, Christopher J. J.
    Corcia, Philippe
    Van Damme, Philip
    Van den Berg, Leonard H.
    Hardiman, Orla
    Rinaldi, Gilberto
    Vanacore, Nicola
    Dickie, Brian
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [45] The double sides of hope: The meaning of hope among amyotrophic lateral sclerosis (ALS) patients
    Hamama-Raz, Yaira
    Norden, Yair
    Buchbinder, Eli
    DEATH STUDIES, 2021, 45 (03) : 238 - 247
  • [46] Neuropathology of Olfactory Ensheathing Cell Transplantation into the Brain of Two Amyotrophic Lateral Sclerosis (ALS) Patients
    Giordana, Maria Teresa
    Grifoni, Silvia
    Votta, Barbara
    Magistrello, Michela
    Vercellino, Marco
    Pellerino, Alessia
    Navone, Roberto
    Valentini, Consuelo
    Calvo, Andrea
    Chio, Adriano
    BRAIN PATHOLOGY, 2010, 20 (04) : 730 - 737
  • [47] Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients
    Anand, A.
    Gupta, P. K.
    Sharma, N. K.
    Prabhakar, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (05) : 788 - 792
  • [48] Implementation and evaluation of an e-health innovation for personalized care for patients with amyotrophic lateral sclerosis (ALS): protocol for a participatory action research study
    Dontje, M. L.
    Kruitwagen-van Reenen, E.
    Visser-Meily, J. M. A.
    Beelen, A.
    IMPLEMENTATION SCIENCE COMMUNICATIONS, 2021, 2 (01):
  • [49] The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe
    Jenkinson, C
    Fitzpatrick, R
    Swash, M
    Peto, V
    JOURNAL OF NEUROLOGY, 2000, 247 (11) : 835 - 840
  • [50] The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe
    C. Jenkinson
    R. Fitzpatrick
    M. Swash
    V. Peto
    Journal of Neurology, 2000, 247 : 835 - 840